Novo Nordisk stock rises after Wegovy recommended by UK’s drug price watchdog
Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4%…
ADHD medication in short supply in Japan as demand soars
Since last fall, Concerta, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD), has been in short…
Eli Lilly reaches deal to bring AI-developed drugs to global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…
FDA approves new ‘Wegovy HD’ with triple the dosage of the semaglutide medication
The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…
Europe’s healthcare – A right or a business model? MEPs face off in The Ring
Published on 18/03/2026 – 21:30 GMT+1 Did you know that the price of a pill and the waiting…
Ozempic is getting generics as low as $15 — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
EU healthcare model ‘cannot be taken for granted’ Commissioner Várhelyi tells Euronews Health Summit
“Health, I think, is still the biggest challenge in front of us for Europe, but also for the…
Ozempic Maker Sued After Woman Died From Stomach Paralysis
The maker of Ozempic, Novo Nordisk, has been hit with a lawsuit over allegations of wrongful death after…
GOP Sen. Johnson investigating FDA rare disease drug rejections
WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…
Battle to get ‘female Viagra’ to market — and how ‘Grey’s Anatomy’ played a role
You’ve heard of the little blue pill. Now, a new documentary is turning the spotlight on the pink…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…